New England Journal of Medicine 2014-12-18

Cytisine--a tobacco treatment hiding in plain sight.

Nancy A Rigotti

Index: N. Engl. J. Med. 371(25) , 2429-30, (2014)

Full Text: HTML

Abstract

A randomized, controlled trial published in this issue of the Journal brings renewed attention to cytisine, a potentially useful pharmacotherapy for smoking cessation that has been hiding in plain sight.1 A naturally occurring plant alkaloid, cytisine has been sold in Eastern Europe as an inexpensive smoking-cessation aid for 50 years but is unavailable elsewhere.2 Two events brought it to broader attention in 2006. First, Etter's review2 of overlooked, older studies suggested a potential efficacy of cytisine for smoking cessation, although a firm conclusion could not be drawn because previous trials did not meet contemporary standards. Second, varenicline, a drug with . . .

Related Compounds

  • L-Nicotine
  • Cytisine

Related Articles:

Effects of environmental enrichment on ERK1/2 phosphorylation in the rat prefrontal cortex following nicotine-induced sensitization or nicotine self-administration.

2015-01-01

[Eur. J. Neurosci. 41(1) , 109-19, (2015)]

Effects of maternal nicotine exposure on thyroid hormone metabolism and function in adult rat progeny.

2015-03-01

[J. Endocrinol. 224(3) , 315-25, (2015)]

A critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats.

2015-03-01

[Addict. Biol. 20(2) , 324-35, (2015)]

Chemical profile and in vivo hypoglycemic effects of Syzygium jambos, Costus speciosus and Tapeinochilos ananassae plant extracts used as diabetes adjuvants in Puerto Rico.

2015-01-01

[BMC Complement Altern. Med. 15 , 244, (2015)]

Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease.

2015-04-01

[Neurobiol. Aging 36 , 1629-38, (2015)]

More Articles...